Nf-kappab Mediated Glucocorticoid Response in the Inner Ear After Acoustic Trauma.
From: Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Journal of neuroscience research
- Publish Date: May 2006
- ISSN: 0360-4012
- Volume: 83
- Issue: 6
- Pages: 1066-76
- Medium: Print
- Language: English
- Citation (JAMA): Tahera Yeasmin, Meltser Inna, Johansson Peter, et al. Nf-kappab Mediated Glucocorticoid Response in the Inner Ear After Acoustic Trauma.. J. Neurosci. Res. May 2006;83:1066-76
Abstract
The inner ear of humans and experimental animals demonstrate an abundance of glucocorticoid receptors (GR). Glucocorticoids (GC) are widely used to treat different hearing disorders; yet the mechanisms of GC action on the inner ear are unknown. We demonstrate how GR can directly modulate hearing sensitivity in response to a moderate acoustic trauma that results in a hearing loss (10-30 dB). The GC agonist (dexamethasone) and the drugs (metyrapone + RU 486) showed opposing effects on hearing threshold shifts. GC agonist (dexamethasone) decreased the hearing threshold whereas pre-treatment with a GC synthesis inhibitor (metyrapone) in combination with a GR antagonist (RU 486) exacerbated auditory threshold shifts (25-60 dB) after acoustic trauma with statistically significant increase in GR mRNA and GR protein compared with the vehicle and acoustic trauma group. Acoustic trauma caused a significant increase in the nuclear transport of NF-kappaB, whereas pre-treatment with the drugs (metyrapone and RU 486) blocked NF-kappaB nuclear transport into spiral ganglion nuclei. An NF-kappaB inhibitor, pyrrolidine dithiocarbamate ammonium blocked the trauma-induced translocation of NF-kappaB and resulted in a hearing loss (45-60) dB. These results indicate that several factors define the responsiveness of the inner ear to GC, including the availability of ligand or receptor, and the nuclear translocation of GR and NF-kappaB. These findings will further our understanding of individual GC responsiveness to steroid treatment, and will help improve the development of pharmaceuticals to selectively target GR in the inner ear for individuals with increased sensitivity to acoustic trauma.
Mesh Headings (Keywords): Acoustic Stimulation, Analysis of Variance, Animals, Auditory Threshold, Blotting, Northern, Disease Models, Animal, Drug Interactions, Ear, Inner, Enzyme Inhibitors, Glucocorticoids, Hearing Loss, Noise-Induced, Immunohistochemistry, In Situ Hybridization, Male, Metyrapone, Mice, Mice, Inbred CBA, Mifepristone, NF-kappa B, Neurons, RNA, Messenger, Receptors, Glucocorticoid, Reverse Transcriptase Polymerase Chain Reaction, Spiral Ganglion, Time Factors
Check for Full Text / PubMed Unique Identifier (PMID): 16493680
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.